View Item 

Show simple item record

Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796
dc.contributor.authorHennan, James K.en_US
dc.contributor.authorHong, Ting-Tingen_US
dc.contributor.authorWillens, David E.en_US
dc.contributor.authorDriscoll, Edward M.en_US
dc.contributor.authorGiboulot, Thierry A.en_US
dc.contributor.authorLucchesi, Benedict Roberten_US
dc.date.accessioned2010-06-01T19:25:38Z
dc.date.available2010-06-01T19:25:38Z
dc.date.issued2002-07en_US
dc.identifier.citationHennan, James K; Hong, Ting-Ting; Willens, David E; Driscoll, Edward M; Giboulot, Thierry A; Lucchesi, Benedict R (2002). "Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796." British Journal of Pharmacology 136(6): 927-937. <http://hdl.handle.net/2027.42/72568>en_US
dc.identifier.issn0007-1188en_US
dc.identifier.issn1476-5381en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72568
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12110617&dopt=citationen_US
dc.format.extent224736 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2002 British Pharmacological Societyen_US
dc.subject.otherArterial Thrombosisen_US
dc.subject.otherGPIIb/IIIa Receptor Antagonisten_US
dc.subject.otherCRL47926en_US
dc.subject.otherAspirinen_US
dc.subject.otherPlatelet Aggregationen_US
dc.subject.otherArachidonic Aciden_US
dc.subject.otherBleeding Timeen_US
dc.subject.otherVessel Wall Injuryen_US
dc.subject.otherArterial Stenosisen_US
dc.titlePrevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherCentre de Recherches du Laboratoire L. Lafon, 19 Avenue du Professeur Cadiot, 94700 Maisons Alfort, Franceen_US
dc.identifier.pmid12110617en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72568/1/sj.bjp.0704744.pdf
dc.identifier.doi10.1038/sj.bjp.0704744en_US
dc.identifier.sourceBritish Journal of Pharmacologyen_US
dc.identifier.citedreferenceBATES, E. R., WALSH, D. G., MU, D. -X., ABRAMS, G. D. & LUCCHESI, B. R. ( 1992 ). Sustained inhibition of vessel wall-platelet interaction after deep coronary artery injury by temporary inhibition of the platelet glycoprotein IIb/IIIa receptor. Coronary Art. Dis., 3, 67 – 76.en_US
dc.identifier.citedreferenceBUSH, L. R. & SHEBUSKI, R. J. ( 1990 ). In vivo models of arterial thrombosis and thrombolysis. FASEB J., 4, 3087 – 3098.en_US
dc.identifier.citedreferenceCHANNING-RODGERS, R. P. & LEVINE, J. ( 1990 ). A critical reappraisal of the bleeding time. Semin. Thromb. Hemost., 16, 1 – 20.en_US
dc.identifier.citedreferenceGENSINI, G. F., COMEGLIO, M. & FALAI, M. ( 1999 ). Advances in antithrombotic therapy of acute myocardial infarction. Am. Heart J., 138, 171 – 176.en_US
dc.identifier.citedreferenceGIBSON, C. M. ( 1999 ). Primary angioplasty compared with thrombolysis: new issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting. Ann. Intern. Med., 130, 841 – 847.en_US
dc.identifier.citedreferenceHENNAN, J. K., HUANG, J., BARRETT, T. D., DRISCOLL, E. M., WILLENS, D. E., PARK, A. M., CROFFORD, L. J. & LUCCHESI, B. R. ( 2001 ). Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation, 104, 820 – 825.en_US
dc.identifier.citedreferenceHUANG, J., REBELLO, S. S., ROSENBURG, L. A., KANEKO, M., SAKURAMA, T. & LUCCHESI, B. R. ( 1999 ). Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model. Eur. J. Pharmacol., 366, 203 – 213.en_US
dc.identifier.citedreferenceLAM, S. C. ( 1992 ). Isolation and characterization of a chymotryptic fragment of platelet glycoprotein IIb/IIIa retaining Arg-Gly-Asp binding activity. J. Biol. Chem., 267, 5649 – 5655.en_US
dc.identifier.citedreferenceLUCCHESI, B. R., ROTE, W. E., DRISCOLL, E. M. & MU, D. -X. ( 1994 ). Prevention of thrombosis and rethrombosis and enhancement of the thrombotic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist. Br. J. Pharmacol., 113, 1333 – 1343.en_US
dc.identifier.citedreferenceMAKKAR, R. R., LITVACK, F., EIGLER, N. L., NAKAMURA, M., IVEY, P. A., FORRESTER, J. S., SHAH, P. K., JORDAN, R. E. & KAUL, S. ( 1997 ). Effects of GPIIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis. Circulation, 95, 1015 – 1021.en_US
dc.identifier.citedreferenceMARCUS, A. J. ( 1994 ). Cellular interactions of platelets in thrombosis. In Thrombosis and hemorrhage. ed. Loscalzo, J. & Schafer, A.I. pp 279 – 291. Boston: Blackwell.en_US
dc.identifier.citedreferenceMICKELSON, J. K., SIMPSON, P. J., CRONIN, M., HOMEISTER, J. W., LAYWELL, E., KITZEN, J. & LUCCHESI, B. R. ( 1990 ). Antiplatelet antibody [7E3 F(ab′)2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model. Circulation, 81, 617 – 627.en_US
dc.identifier.citedreferencePHILLIPS, D. R., TENG, W., ARFSTEN, A., NANNIZZI-ALAIMO, L., WHITE, M. M., LONGHURST, C., SHATTIL, S. J., RANDOLPH, A., JAKUBOWSKI, J. A., JENNINGS, L. K. & SCARBOROUGH, R. M. ( 1997 ). Effect of calcium on GPIIb/IIIa interactions with integrilin: enhanced GPIIb/IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation, 96, 1488 – 1494.en_US
dc.identifier.citedreferenceREBELLO, S. S., HUANG, J., SAITO, K. & LUCCHESI, B. R. ( 1998 ). The in vivo efficacy of SM-20302, a GPIIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood. Arterioscler. Thromb. Vasc. Biol., 18, 954 – 960.en_US
dc.identifier.citedreferenceROMSON, J. L., HAACK, D. W. & LUCCHESI, B. R. ( 1980 ). Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of antithrombotic agents. Thromb. Res., 17, 841 – 853.en_US
dc.identifier.citedreferenceROTE, W. E., DAVIS, J. H., MOUSA, S. A., REILLY, R. M. & LUCCHESI, B. R. ( 1994b ). Antithrombotic effects of DMP-728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis. J. Cardiovasc. Pharmacol., 23, 681 – 689.en_US
dc.identifier.citedreferenceROTE, W. E., MU, D-X., BATES, E. R., NEDLEMAN, M. A. & LUCCHESI, B. R. ( 1994c ). Prevention of rethrombosis after coronary thrombolysis in a chronic canine model: I. Adjunctive therapy with monoclonal antibody 7E3 F(ab′)2 fragment. J. Cardiovasc. Pharmacol., 23, 194 – 202.en_US
dc.identifier.citedreferenceROTE, W. E., NEDELMAN, M. A., MU, D. -X., MANLEY, P. J., WEISMAN, H., CUNNINGHAM, M. R. & LUCCHESI, B. R. ( 1994a ). Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys. Stroke, 25, 1223 – 1232.en_US
dc.identifier.citedreferenceROTE, W. E., WERNS, S. E., DAVIS, J. H., FEIGEN, L. P., KILGORE, K. S. & LUCCHESI, B. R. ( 1993 ). Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Cardiovasc. Res., 27, 500 – 507.en_US
dc.identifier.citedreferenceSPINLER, S. A., HILLEMAN, D. E., CHENG, J. W., HOWARD, P. A., MAURO, V. F., LOPEZ, L. M., MUNGER, M. A., GARDNER, S. F. & NAPPI, J. M. ( 2001 ). New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann. Pharmacother., 35, 589 – 617.en_US
dc.identifier.citedreferenceSTEINER, B., COUSAT, D., TRZECIAK, A., GILLESSEN, D. & HADVARY, P. ( 1989 ). Calcium-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb/IIIa complex. J. Biol. Chem., 264, 13102 – 13108.en_US
dc.identifier.citedreferenceVANE, J. R. ( 1971 ). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol., 231, 232 – 235.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
sj.bjp.0704744.pdf
Size:
219.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.